Babs G. Taal

9.3k total citations · 1 hit paper
109 papers, 6.0k citations indexed

About

Babs G. Taal is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Babs G. Taal has authored 109 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Oncology, 45 papers in Epidemiology and 33 papers in Neurology. Recurrent topics in Babs G. Taal's work include Neuroendocrine Tumor Research Advances (41 papers), Neuroblastoma Research and Treatments (32 papers) and Lung Cancer Research Studies (21 papers). Babs G. Taal is often cited by papers focused on Neuroendocrine Tumor Research Advances (41 papers), Neuroblastoma Research and Treatments (32 papers) and Lung Cancer Research Studies (21 papers). Babs G. Taal collaborates with scholars based in Netherlands, Germany and Italy. Babs G. Taal's co-authors include Otto Visser, Henk Boot, Catharina M. Korse, Neil K. Aaronson, Hans F. A. Vasen, Fred H. Menko, Johanna M. Zuetenhorst, Mirjam A. G. Sprangers, A. te Velde and Jan H. Kleibeuker and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Babs G. Taal

109 papers receiving 5.8k citations

Hit Papers

ENETS Consensus Guidelines Update for Gastroduodenal Neur... 2016 2026 2019 2022 2016 100 200 300

Peers

Babs G. Taal
Shouhao Zhou United States
Leah Ben‐Porat United States
Allan Siperstein United States
George A. Poultsides United States
Shishir K. Maithel United States
Shouhao Zhou United States
Babs G. Taal
Citations per year, relative to Babs G. Taal Babs G. Taal (= 1×) peers Shouhao Zhou

Countries citing papers authored by Babs G. Taal

Since Specialization
Citations

This map shows the geographic impact of Babs G. Taal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Babs G. Taal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Babs G. Taal more than expected).

Fields of papers citing papers by Babs G. Taal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Babs G. Taal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Babs G. Taal. The network helps show where Babs G. Taal may publish in the future.

Co-authorship network of co-authors of Babs G. Taal

This figure shows the co-authorship network connecting the top 25 collaborators of Babs G. Taal. A scholar is included among the top collaborators of Babs G. Taal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Babs G. Taal. Babs G. Taal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korse, Catharina M., Babs G. Taal, Marie‐Louise F. van Velthuysen, & Otto Visser. (2013). Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: Experience of two decades of cancer registry. European Journal of Cancer. 49(8). 1975–1983. 183 indexed citations
2.
Korse, Catharina M., Johannes M.G. Bonfrèr, Warner Prevoo, Paul Baas, & Babs G. Taal. (2011). Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours. Tumor Biology. 32(4). 647–652. 12 indexed citations
3.
Stokkel, Marcel P. M., Daphne D. D. Rietbergen, Catharina M. Korse, & Babs G. Taal. (2011). Somatostatin receptor scintigraphy and chromogranin A assay in staging and follow-up of patients with well-differentiated neuroendocrine tumors. Nuclear Medicine Communications. 32(8). 731–737. 9 indexed citations
4.
Gerven, Marcel van, Babs G. Taal, & Peter Lucas. (2008). Dynamic Bayesian networks as prognostic models for clinical patient management. Journal of Biomedical Informatics. 41(4). 515–529. 74 indexed citations
5.
Gerven, Marcel van & Babs G. Taal. (2006). Structure and Parameters of a Bayesian Network for Carcinoid Prognosis. CTIT technical report series. 1 indexed citations
6.
Cappel, Wouter H. de Vos tot Nederveen, Fokko M. Nagengast, Gerrit Griffioen, et al.. (2002). Surveillance for hereditary nonpolyposis colorectal cancer - A long-term study on 114 families. University of Groningen research database (University of Groningen / Centre for Information Technology). 142 indexed citations
7.
Zuetenhorst, Johanna M., et al.. (2002). Evaluation of 111In-pentetreotide, 131I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease. Nuclear Medicine Communications. 23(8). 735–741. 56 indexed citations
8.
Cappel, Wouter H. de Vos tot Nederveen, Fokko M. Nagengast, Gerrit Griffioen, et al.. (2002). Surveillance for Hereditary Nonpolyposis Colorectal Cancer. Diseases of the Colon & Rectum. 45(12). 1588–1594. 132 indexed citations
9.
Bongard, H.J.G.D. van den, Henk Boot, Paul Baas, & Babs G. Taal. (2002). The role of parallel stent insertion in patients with esophagorespiratory fistulas. Gastrointestinal Endoscopy. 55(1). 110–115. 51 indexed citations
10.
Jong, Daphne de, Henk Boot, & Babs G. Taal. (2000). Histological Grading with Clinical Relevance in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. Recent results in cancer research. 156. 27–32. 22 indexed citations
11.
Taal, Babs G., et al.. (1999). Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG). European Journal of Gastroenterology & Hepatology. 11(10). 1157–1184. 20 indexed citations
12.
Taal, Babs G., et al.. (1998). Expandable stents compared to conventional plastic endoprostheses in malignant oesophageal obstruction, especially in cardiac cancer and fistulas. European Journal of Gastroenterology & Hepatology. 10(9). 745–752. 14 indexed citations
13.
Hoogenraad, W.J., A. Lusinchi, Babs G. Taal, et al.. (1996). Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: An EORTC GITCCG study. European Journal of Cancer. 32(8). 1310–1313. 16 indexed citations
14.
Taal, Babs G., Renato A. Valdés Olmos, Henk Boot, & Cornelis A. Hoefnagel. (1995). Assessment of sucralfate coating by sequential scintigraphic imaging in radiation-induced esophageal lesions. Gastrointestinal Endoscopy. 41(2). 109–114. 17 indexed citations
15.
Taal, Babs G., Paul Cohen, Hans Peterse, Henk Boot, & Guido N.J. Tytgat. (1995). Recurrent esophagorespiratory fistula in a patient with metastatic breast cancer: long-term palliation with endoprostheses and hormonal therapy. Gastrointestinal Endoscopy. 42(1). 84–88. 4 indexed citations
16.
Vasen, Hans F. A., Babs G. Taal, G Griffioen, et al.. (1994). Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols.. Gut. 35(9). 1262–1266. 36 indexed citations
17.
Simonetti, Giovanni, Anne-Charlotte Dubbelman, W W ten Bokkel Huinink, et al.. (1994). Toxicity grading systems. Annals of Oncology. 5(2). 113–117. 49 indexed citations
18.
Taal, Babs G., J. M. V. Burgers, P. van Heerde, A. A. M. Hart, & R. Somers. (1993). The clinical spectrum and treatment of primary non-Hodgkin's lymphoma of the stomach. Annals of Oncology. 4(10). 839–846. 74 indexed citations
19.
Olmos, R.A. Valdés, et al.. (1991). Imaging and retention measurements of selenium 75 homocholic acid conjugated with taurine, and the carbon 14 glycochol breath test to document ileal dysfunction due to late radiation damage. European Journal of Nuclear Medicine and Molecular Imaging. 18(2). 124–128. 12 indexed citations
20.
Hoefnagel, C.A., P.A. Voûte, Jan de Kraker, et al.. (1988). Side effects of I-131-MIBG therapy of neural crest tumors. Australian and New Zealand Journal of Medicine. 18(3). 504. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026